✦ LIBER ✦

Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes

✍ Scribed by M. N. Feinglos; M. F. Saad; F. X. Pi-Sunyer; B. An; O. Santiago; on behalf of the Liraglutide Dose-Response Study Group

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synergistic effect of the human GLP-1 an

✍ C. L. Brand; E. D. Galsgaard; D. Tornehave; J. Rømer; C. F. Gotfredsen; K. Wasse 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB

Liraglutide, a once-daily human GLP-1 an

✍ Marre, M. (author);Shaw, J. (author);Brändle, M. (author);Bebakar, W. M.W. (auth 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 803 KB

Liraglutide, a once-daily human GLP-1 an

✍ Marre, M. (author);Shaw, J. (author);Brändle, M. (author);Bebakar, W. M.W. (auth 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 803 KB

Efficacy of liraglutide, a glucagon-like

✍ Yuya Fujishima, Norikazu Maeda, Kana Inoue, Susumu Kashine, Hitoshi Nishizawa, A 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 351 KB

PDB7 GLYCAEMIC CONTROL AND INSULIN UTILI

✍ E Heintjes; TL Thomsen; FJA Penning; T Christensen; RMC Herings 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Safety, tolerability, pharmacokinetics a

✍ Seino, Yutaka; Nakajima, Hiromu; Miyahara, Hajime; Kurita, Takashi; Bush, Mark A 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 230 KB